Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.63 - $2.96 $99,243 - $466,285
-157,529 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.43 - $3.14 $896 - $1,968
627 Added 0.4%
157,529 $318,000
Q4 2021

Feb 15, 2022

BUY
$2.7 - $4.76 $39,293 - $69,272
14,553 Added 10.22%
156,902 $425,000
Q3 2021

Nov 15, 2021

BUY
$4.06 - $5.8 $20,364 - $29,092
5,016 Added 3.65%
142,349 $635,000
Q2 2021

Aug 16, 2021

BUY
$5.02 - $7.05 $61,645 - $86,574
12,280 Added 9.82%
137,333 $797,000
Q1 2021

May 18, 2021

SELL
$4.81 - $10.34 $2,174 - $4,673
-452 Reduced 0.36%
125,053 $878,000
Q3 2020

Nov 17, 2020

BUY
$4.82 - $7.72 $79,481 - $127,302
16,490 Added 15.13%
125,505 $732,000
Q2 2020

Aug 17, 2020

BUY
$5.69 - $9.69 $187,616 - $319,508
32,973 Added 43.36%
109,015 $736,000
Q1 2020

May 13, 2020

SELL
$3.77 - $11.0 $9,093 - $26,532
-2,412 Reduced 3.07%
76,042 $484,000
Q3 2019

Nov 15, 2019

BUY
$3.93 - $15.35 $12,886 - $50,332
3,279 Added 4.36%
78,454 $308,000
Q2 2019

Aug 14, 2019

BUY
$12.81 - $25.67 $29,129 - $58,373
2,274 Added 3.12%
75,175 $1.12 Million
Q1 2019

May 09, 2019

SELL
$17.66 - $30.28 $28,626 - $49,083
-1,621 Reduced 2.18%
72,901 $1.81 Million
Q4 2018

Feb 13, 2019

BUY
$11.63 - $32.67 $19,526 - $54,852
1,679 Added 2.3%
74,522 $1.34 Million
Q3 2018

Nov 14, 2018

SELL
$29.37 - $49.48 $734 - $1,237
-25 Reduced 0.03%
72,843 $2.14 Million
Q2 2018

Aug 14, 2018

BUY
$42.06 - $62.4 $250,004 - $370,905
5,944 Added 8.88%
72,868 $3.31 Million
Q1 2018

May 15, 2018

SELL
$50.12 - $67.72 $117,581 - $158,871
-2,346 Reduced 3.39%
66,924 $3.53 Million
Q4 2017

Feb 14, 2018

SELL
$57.69 - $84.58 $62,651 - $91,853
-1,086 Reduced 1.54%
69,270 $4.71 Million
Q3 2017

Nov 13, 2017

BUY
$67.17 - $84.81 $4.73 Million - $5.97 Million
70,356
70,356 $5.8 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.